ArticleFrontiers in immunology2022

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern.

Irina A Favorskaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.